L
Leading Pharma
A Airfield, NJ based generic pharmaceutical company
About Leading Pharma
Leading Pharma is a U.S.-based company specializing in the development, manufacturing, and distribution of generic pharmaceutical products. The company focuses on producing oral solid dose products under its own label, ensuring stringent regulatory compliance and high-quality standards. Leading Pharma serves a diverse range of clients, including healthcare providers, pharmacies, and distributors, primarily within the U.S. market. The business model revolves around manufacturing and selling generic drugs, which are cost-effective alternatives to brand-name medications. Revenue is generated through the sale of these pharmaceutical products. The company also explores partnership and licensing opportunities in the areas of finished dose, active pharmaceutical ingredients (APIs), and authorized generics. Leading Pharma's commitment to quality and safety is overseen by a dedicated regulatory and quality control team, ensuring that products meet rigorous standards from initial development to customer delivery. The company prides itself on outstanding customer service, innovative marketing strategies, and efficient manufacturing and distribution processes.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2014
- Headquarters
- Fairfield, United States
- Employees
- 105
- Open positions
- None listed
- Dealroom signal
- 36.2/100
- Industry
- Health
- Sub-industry
- Pharmaceutical
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Jan 2018 | $40M | $160M | Signet Healthcare Partners · Cane Investment Partners · Crestline Investors | — |
Growth signals
Latest recorded traffic for Leading Pharma is 2.3K monthly website visits, up 109.1% over the last three months. Leading Pharma's team declined 1.9% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later3 investors entered at this stage
Signet Healthcare Partners- CPCane Investment Partners
Crestline Investors
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Leading Pharma on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Leading Pharma’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.